Merck & Co., Inc. insider trades: Harpoon Therapeutics (HARP) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Merck & Co., Inc. reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | HARP | ↑ Buy | 21,397,205 | $23.00 | $492.1M | Indirect | Mar 11, 2024 (0d) |
| Apr 8, 2019 | NGM | ↑ Buy | 4,121,683 | $16.00 | $65.9M | Indirect | Apr 9, 2019 (1d) |
| Oct 1, 2018 | STRO | ↑ Buy | 666,666 | $15.00 | $10.0M | Indirect | Oct 2, 2018 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Merck & Co., Inc.'s insider trades
Merck & Co., Inc. is an insider at Harpoon Therapeutics (HARP). Since Oct 1, 2018, it has reported 3 open-market purchases worth $568.1M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (4 filings), conversions (3 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HARP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.